Menu
GeneBe

SOCS2

suppressor of cytokine signaling 2, the group of Suppressors of cytokine signaling|SH2 domain containing

Basic information

Region (hg38): 12:93569813-93583487

Links

ENSG00000120833NCBI:8835OMIM:605117HGNC:19382Uniprot:O14508AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the SOCS2 gene.

  • Inborn genetic diseases (11 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the SOCS2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
11
clinvar
11
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 11 0 0

Variants in SOCS2

This is a list of pathogenic ClinVar variants found in the SOCS2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
12-93572946-C-T not specified Uncertain significance (Jun 13, 2023)2560016
12-93572974-C-T not specified Uncertain significance (Jun 21, 2021)2224235
12-93573031-A-G not specified Uncertain significance (Sep 20, 2022)2312666
12-93574961-G-A not specified Uncertain significance (Jan 26, 2022)2273948
12-93574968-A-G not specified Uncertain significance (Apr 04, 2023)2532442
12-93574992-G-A not specified Uncertain significance (Dec 22, 2023)3167397
12-93575052-A-G not specified Uncertain significance (Jun 24, 2022)2297559
12-93575055-C-A not specified Uncertain significance (Jun 28, 2022)2214687
12-93575061-C-T not specified Uncertain significance (Dec 19, 2022)2337262
12-93575090-A-T not specified Uncertain significance (Feb 01, 2023)2456849
12-93575102-T-C not specified Uncertain significance (Jan 16, 2024)3167398
12-93575108-G-A not specified Uncertain significance (Aug 22, 2023)2594005
12-93575159-G-A not specified Uncertain significance (Jun 11, 2021)2232396

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
SOCS2protein_codingprotein_codingENST00000340600 213674
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.6300.364125724011257250.00000398
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.37711120.6350.000005921244
Missense in Polyphen1938.9510.4878471
Synonymous0.7184248.40.8690.00000271403
Loss of Function2.1917.430.1353.79e-791

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.00009920.0000992
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.000.00
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: SOCS family proteins form part of a classical negative feedback system that regulates cytokine signal transduction. SOCS2 appears to be a negative regulator in the growth hormone/IGF1 signaling pathway. Probable substrate recognition component of a SCF-like ECS (Elongin BC-CUL2/5-SOCS-box protein) E3 ubiquitin- protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins.;
Pathway
Type II diabetes mellitus - Homo sapiens (human);Jak-STAT signaling pathway - Homo sapiens (human);Prolactin signaling pathway - Homo sapiens (human);Insulin signaling pathway - Homo sapiens (human);IGF-Core;Leptin signaling pathway;Prolactin Signaling Pathway;JAK-STAT;Ectoderm Differentiation;Leptin Insulin Overlap;Growth hormone receptor signaling;Prolactin;Cytokine Signaling in Immune system;Post-translational protein modification;Metabolism of proteins;Growth hormone signaling;Immune System;Neddylation;IL3;IL2-mediated signaling events (Consensus)

Recessive Scores

pRec
0.482

Intolerance Scores

loftool
0.406
rvis_EVS
0.19
rvis_percentile_EVS
66.57

Haploinsufficiency Scores

pHI
0.564
hipred
Y
hipred_score
0.733
ghis
0.429

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.977

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Socs2
Phenotype
hematopoietic system phenotype; reproductive system phenotype; respiratory system phenotype; liver/biliary system phenotype; renal/urinary system phenotype; skeleton phenotype; immune system phenotype; digestive/alimentary phenotype; limbs/digits/tail phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); homeostasis/metabolism phenotype;

Gene ontology

Biological process
regulation of cell growth;JAK-STAT cascade;lactation;regulation of signal transduction;positive regulation of signal transduction;protein ubiquitination;response to estradiol;cellular response to hormone stimulus;interleukin-7-mediated signaling pathway;negative regulation of multicellular organism growth;negative regulation of apoptotic process;regulation of phosphatidylinositol 3-kinase activity;post-translational protein modification;positive regulation of neuron differentiation;negative regulation of JAK-STAT cascade;negative regulation of insulin receptor signaling pathway;phosphatidylinositol phosphorylation;growth hormone receptor signaling pathway;mammary gland alveolus development
Cellular component
cytoplasm;cytosol;phosphatidylinositol 3-kinase complex
Molecular function
SH3/SH2 adaptor activity;growth hormone receptor binding;insulin-like growth factor receptor binding;protein binding;JAK pathway signal transduction adaptor activity;1-phosphatidylinositol-3-kinase regulator activity